{"transactions":[{"id":2637807,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":137464,"kind":"organization","name":"Sands Capital Ventures Discovery Fund III, L.P.","position":1,"cik":"0001870491","reported_name":"Sands Capital Ventures Discovery Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137465,"kind":"organization","name":"Sands Capital Global Venture Fund II, L.P.","position":2,"cik":"0001870493","reported_name":"Sands Capital Global Venture Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137466,"kind":"organization","name":"Sands Capital Life Sciences Pulse Fund, LLC","position":3,"cik":"0001870490","reported_name":"Sands Capital Life Sciences Pulse Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72648,"kind":"person","name":"SANDS FRANK M.","position":4,"cik":"0001870494","reported_name":"SANDS FRANK M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-07-08T21:21:31.000Z","date":"2021-07-06","kind":"exercise","acquired":false,"shares":1842346,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Consists of 921,173 shares of Common Stock held by Sands Venture Fund and 921,173 shares of Common Stock held by Sands Pulse Fund. Sands Capital Global Venture Fund II-GP, L.P. (\"Sands Venture GP L.P.\") is the general partner of Sands Venture Fund and Sands Capital Global Venture Discovery Fund II-GP, LLC (\"Sands Venture GP LLC\") is the general partner of Sands Venture GP L.P. Sands Venture GP L.P. and Sands Venture GP LLC  each disclaims beneficial ownership of such securities except to the extent of its respective pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Frank M. Sands holds ultimate voting and investment power over securities held by Sands Discovery Fund, Sands Venture Fund and Sands Pulse Fund. Mr. Sands disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1842346},"source":{"system":"sec-edgar","filing":"0000899243-21-027891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000089924321027891/doc4.xml","form_type":"4"}},{"id":2637806,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":137464,"kind":"organization","name":"Sands Capital Ventures Discovery Fund III, L.P.","position":1,"cik":"0001870491","reported_name":"Sands Capital Ventures Discovery Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137465,"kind":"organization","name":"Sands Capital Global Venture Fund II, L.P.","position":2,"cik":"0001870493","reported_name":"Sands Capital Global Venture Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137466,"kind":"organization","name":"Sands Capital Life Sciences Pulse Fund, LLC","position":3,"cik":"0001870490","reported_name":"Sands Capital Life Sciences Pulse Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72648,"kind":"person","name":"SANDS FRANK M.","position":4,"cik":"0001870494","reported_name":"SANDS FRANK M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2021-07-08T21:21:31.000Z","date":"2021-07-06","kind":"exercise","acquired":false,"shares":1124729,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Consists of 1,124,719 shares of Common Stock held by Sands Capital Ventures Discovery Fund III, L.P. (\"Sands Discovery Fund \"). Sands Capital Ventures Discovery Fund III-GP, LLC (\"Sands Discovery GP\") is the general partner of Sands Discovery Fund. Sands Discovery GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Frank M. Sands holds ultimate voting and investment power over securities held by Sands Discovery Fund, Sands Venture Fund and Sands Pulse Fund. Mr. Sands disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1124729},"source":{"system":"sec-edgar","filing":"0000899243-21-027891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000089924321027891/doc4.xml","form_type":"4"}},{"id":2637805,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":137464,"kind":"organization","name":"Sands Capital Ventures Discovery Fund III, L.P.","position":1,"cik":"0001870491","reported_name":"Sands Capital Ventures Discovery Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137465,"kind":"organization","name":"Sands Capital Global Venture Fund II, L.P.","position":2,"cik":"0001870493","reported_name":"Sands Capital Global Venture Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137466,"kind":"organization","name":"Sands Capital Life Sciences Pulse Fund, LLC","position":3,"cik":"0001870490","reported_name":"Sands Capital Life Sciences Pulse Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72648,"kind":"person","name":"SANDS FRANK M.","position":4,"cik":"0001870494","reported_name":"SANDS FRANK M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T21:21:31.000Z","date":"2021-07-06","kind":"purchase","acquired":true,"shares":450000,"price":14.88,"value":6696000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents 225,000 shares of Common Stock acquired by Sands Capital Global Venture Fund II, L.P. (\"Sands Venture Fund\") and 225,000 shares of Common Stock acquired by ands Capital Life Sciences Pulse Fund (\"Sands Pulse Fund\") in connection with the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Consists of 921,173 shares of Common Stock held by Sands Venture Fund and 921,173 shares of Common Stock held by Sands Pulse Fund. Sands Capital Global Venture Fund II-GP, L.P. (\"Sands Venture GP L.P.\") is the general partner of Sands Venture Fund and Sands Capital Global Venture Discovery Fund II-GP, LLC (\"Sands Venture GP LLC\") is the general partner of Sands Venture GP L.P. Sands Venture GP L.P. and Sands Venture GP LLC  each disclaims beneficial ownership of such securities except to the extent of its respective pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Frank M. Sands holds ultimate voting and investment power over securities held by Sands Discovery Fund, Sands Venture Fund and Sands Pulse Fund. Mr. Sands disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":3417075,"source":{"system":"sec-edgar","filing":"0000899243-21-027891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000089924321027891/doc4.xml","form_type":"4"}},{"id":2637804,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":137464,"kind":"organization","name":"Sands Capital Ventures Discovery Fund III, L.P.","position":1,"cik":"0001870491","reported_name":"Sands Capital Ventures Discovery Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137465,"kind":"organization","name":"Sands Capital Global Venture Fund II, L.P.","position":2,"cik":"0001870493","reported_name":"Sands Capital Global Venture Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137466,"kind":"organization","name":"Sands Capital Life Sciences Pulse Fund, LLC","position":3,"cik":"0001870490","reported_name":"Sands Capital Life Sciences Pulse Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72648,"kind":"person","name":"SANDS FRANK M.","position":4,"cik":"0001870494","reported_name":"SANDS FRANK M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T21:21:31.000Z","date":"2021-07-06","kind":"exercise","acquired":true,"shares":1842346,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Consists of 921,173 shares of Common Stock held by Sands Venture Fund and 921,173 shares of Common Stock held by Sands Pulse Fund. Sands Capital Global Venture Fund II-GP, L.P. (\"Sands Venture GP L.P.\") is the general partner of Sands Venture Fund and Sands Capital Global Venture Discovery Fund II-GP, LLC (\"Sands Venture GP LLC\") is the general partner of Sands Venture GP L.P. Sands Venture GP L.P. and Sands Venture GP LLC  each disclaims beneficial ownership of such securities except to the extent of its respective pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Frank M. Sands holds ultimate voting and investment power over securities held by Sands Discovery Fund, Sands Venture Fund and Sands Pulse Fund. Mr. Sands disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":2967075,"source":{"system":"sec-edgar","filing":"0000899243-21-027891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000089924321027891/doc4.xml","form_type":"4"}},{"id":2637803,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":137464,"kind":"organization","name":"Sands Capital Ventures Discovery Fund III, L.P.","position":1,"cik":"0001870491","reported_name":"Sands Capital Ventures Discovery Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137465,"kind":"organization","name":"Sands Capital Global Venture Fund II, L.P.","position":2,"cik":"0001870493","reported_name":"Sands Capital Global Venture Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":137466,"kind":"organization","name":"Sands Capital Life Sciences Pulse Fund, LLC","position":3,"cik":"0001870490","reported_name":"Sands Capital Life Sciences Pulse Fund, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":72648,"kind":"person","name":"SANDS FRANK M.","position":4,"cik":"0001870494","reported_name":"SANDS FRANK M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T21:21:31.000Z","date":"2021-07-06","kind":"exercise","acquired":true,"shares":1124729,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A-1 Preferred Stock and each share of Series B Preferred Stock automatically converted into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Consists of 1,124,719 shares of Common Stock held by Sands Capital Ventures Discovery Fund III, L.P. (\"Sands Discovery Fund \"). Sands Capital Ventures Discovery Fund III-GP, LLC (\"Sands Discovery GP\") is the general partner of Sands Discovery Fund. Sands Discovery GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Frank M. Sands holds ultimate voting and investment power over securities held by Sands Discovery Fund, Sands Venture Fund and Sands Pulse Fund. Mr. Sands disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":1124729,"source":{"system":"sec-edgar","filing":"0000899243-21-027891","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576885/000089924321027891/doc4.xml","form_type":"4"}}]}